Warp Speed, NIH Develop Master Protocols For Monoclonal Antibodies

By Beth Wang / July 13, 2020 at 7:15 PM
Operation Warp Speed and the National Institutes of Health have developed two master protocols for COVID-19 monoclonal antibody clinical trials, FDA drug center director Janet Woodcock told reporters on a press call Monday (July 13). One protocol will test the use of monoclonal antibodies in the outpatient setting and another is for inpatient use. They’re both scheduled to start testing this month. Woodcock said the Operation Warp Speed team hopes to have data on the effectiveness of the antibodies by...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.